Probenecid And Colchicine Tablet
Product Images NDC 0591-5325

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Probenecid And Colchicine (NDC 0591-5325). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Probenecid Structural Formula (Image 1)

Chemical structure of the active ingredient shown, depicting a benzene ring substituted with a carboxylic acid group (COOH) and a butyl sulfonamide group ((CH3CH2CH2)2NSO2).*

FDA Label Image

Colchicine Structural Formula (Image 2)

Chemical structure diagram showing the molecular arrangement of the active ingredients Probenecid and Colchicine as labeled, depicting rings and functional groups including methoxy and amide groups.*

FDA Label Image

1 (Image 3)

Label for Probenecid and Colchicine Tablets USP, containing 500 mg of Probenecid and 0.5 mg of Colchicine per tablet. The label shows a white oval tablet imprinted with '5325'. The product is manufactured by Watson Pharma Private Limited in India and distributed by Actavis Pharma, Inc. in Parsippany, NJ, USA. The package contains 100 tablets and is marked Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.